Initial Management of Palpitations
The initial management for a patient presenting with palpitations should include a 12-lead ECG, detailed history focusing on the characteristics of palpitations, and 48-hour ambulatory ECG monitoring for patients with frequent or sustained episodes. 1, 2
Initial Evaluation
- Obtain a 12-lead ECG as an essential first diagnostic step to identify baseline abnormalities or capture arrhythmias if present during the visit 1, 2
- Assess for signs of hemodynamic instability that would require immediate intervention (syncope, near-syncope, dyspnea, or chest pain) 1
- Document detailed characteristics of palpitations including:
- Onset and termination pattern (sudden vs. gradual)
- Duration and frequency of episodes
- Associated symptoms
- Precipitating factors (exercise, stress, caffeine, alcohol) 2
- Perform physical examination to assess for signs of structural heart disease or thyroid dysfunction 2
Diagnostic Testing Based on Frequency of Episodes
- For patients with frequent or sustained palpitations, 48-hour ambulatory ECG monitoring is recommended as the first-line diagnostic test 3, 1
- For less frequent episodes, an event recorder or wearable loop recorder may be more appropriate 1, 2
- For rare but concerning episodes, an implantable loop recorder (ILR) may be considered 3, 2
- Echocardiography should be performed to exclude structural heart disease, especially in patients with sustained palpitations or concerning associated symptoms 1, 2
Management Based on Identified Cause
Atrial Fibrillation
- Implement appropriate rate control or rhythm control strategies based on symptom severity 3, 1
- Beta-blockers, diltiazem, verapamil, or digoxin are recommended as first-choice drugs for patients with AF and LVEF >40% 3
- For patients with AF and LVEF ≤40%, beta-blockers and/or digoxin are recommended 3
- Assess stroke risk and initiate anticoagulation if indicated 1
Supraventricular Tachycardia
- Initial management may include vagal maneuvers, beta-blockers, or referral for catheter ablation 1
- Consider combination rate control therapy if a single drug does not control symptoms 3
Ventricular Arrhythmias
- Patients with sustained ventricular tachycardia require hospitalization and initiation of appropriate antiarrhythmic therapy 1
- Consider referral for electrophysiology study and possible ablation 3
Special Considerations
- For patients with palpitations and syncope, more urgent evaluation is required, including 12-lead ECG, exercise testing, and 48-hour ambulatory ECG monitoring 3, 1
- Patients with pre-excitation on resting ECG (Wolff-Parkinson-White syndrome) and paroxysmal palpitations should be referred to electrophysiology 2
- For vagally mediated palpitations (occurring at night or after meals), adrenergic blocking drugs or digitalis may worsen symptoms 3
- For adrenergically induced palpitations (typically occurring during daytime in patients with organic heart disease), beta-blockers are the initial treatment of choice 3
Indications for Specialist Referral
- Wide complex tachycardia of unknown origin 2
- Narrow complex tachycardia with drug resistance or intolerance 2
- Severe symptoms during palpitations (syncope, pre-syncope) 1
- Evidence of structural heart disease 1, 2
- Palpitations associated with family history of sudden cardiac death 3
Management Algorithm
- Assess hemodynamic stability - if unstable, provide immediate intervention
- Obtain 12-lead ECG and detailed history
- If cause identified on initial evaluation, treat accordingly
- If cause not identified, proceed with ambulatory monitoring based on frequency:
- Frequent episodes: 48-hour Holter monitor
- Intermittent episodes: Event recorder or wearable loop recorder
- Rare episodes: Implantable loop recorder
- Perform echocardiography to assess for structural heart disease
- Refer to cardiology/electrophysiology if concerning features present or diagnosis remains unclear after initial evaluation
By following this systematic approach, most causes of palpitations can be identified and appropriately managed, improving patient outcomes and quality of life 4, 5.